Surgical resection of brain metastases from renal cell carcinoma in 50 patients

Urology
M WrońskiJ H Galicich

Abstract

Metastases are frequently diagnosed among patients with renal cell carcinoma (RCC). Of 709 patients with brain metastases (BMET) who were operated on at our institution between 1974 and 1993, 50 (7%) were of renal origin. Medical records were reviewed retrospectively. Survival time was calculated by the Kaplan-Meier method and Cox proportional hazards model. There were 38 men and 12 women. The median age was 60 years. The primary RCC was resected in 47 patients. Forty patients had a metachronous diagnosis of RCC and BMET. Median interval between the diagnosis of RCC and BMET was 17 months. In all 50 patients overall median survival (MS) from diagnosis of primary RCC was 31.4 months and from craniotomy was 12.6 months. Postoperative mortality was 10% (5 patients). In patients with primary RCC in the left kidney (n=25) versus right kidney (n=25) median survival from craniotomy was longer; 21.3 versus 7.4 months (P<0.014). Twenty-three patients (46%) had intratumoral hemorrhage. Eight patients had cerebellar metastasis (MS, 3.0 months) and 9 had multiple metastases resected (MS, 7.6 months). Thirty-eight patients had both brain and pulmonary metastases, and 16 of them had pulmonary resection (MS, 18.6 versus 8.0 months; P<0.03). T...Continue Reading

References

Nov 1, 1978·The Journal of Urology·M J O'deaP E Bernatz
Dec 11, 1975·The Journal of Urology·B M Tolia, W F Whitmore
Jan 1, 1992·Journal of Surgical Oncology·H B TongaonkarM R Kamat
Jul 1, 1992·The Annals of Thoracic Surgery·H W PogrebniakH I Pass
Aug 1, 1990·Urology·R A BadalamentJ H Galicich
Nov 1, 1985·International Journal of Radiation Oncology, Biology, Physics·V Onufrey, M Mohiuddin
Aug 1, 1988·The Journal of Urology·M K DineenR P Huben
Jan 1, 1987·Journal of Neuro-oncology·P C GayT L Cascino
Oct 1, 1986·The Journal of Urology·J B deKernion
Apr 1, 1986·Urology·M GolimbuP Morales
Oct 1, 1965·Journal of Neurosurgery·R G Vieth, G L Odom
Jun 1, 1967·The Journal of Urology·R G Middleton
Mar 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A DeckerG D Cummings
Jan 1, 1983·Acta neurochirurgica·F M Gagliardi, S Mercuri
May 15, 1980·Cancer·K R WinstonE G Fischer
Oct 1, 1995·Journal of Neurosurgery·R K BindalS H Taylor
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S D FossåJ P Droz
Jan 5, 1963·British Medical Journal·P RICHARDS, W McKISSOCK
Jul 2, 2010·Current Opinion in Urology·Rodney H Breau, Michael L Blute
Aug 1, 2013·Clinical Journal of Oncology Nursing·Alixis Van Horn, Cynthia Harrison
Aug 13, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Christian StrongJean-Valery C E Coumans

❮ Previous
Next ❯

Citations

Dec 23, 2006·Der Urologe. Ausg. A·S BuseM Hohenfellner
Mar 26, 2005·World Journal of Urology·Alexander MuacevicBerndt Wowra
Dec 21, 2004·Neurosurgical Review·Andreas M StarkH Maximilian Mehdorn
Oct 21, 2011·Current Oncology Reports·Lakshmi NayakPatrick Y Wen
Dec 22, 2004·Current Urology Reports·John S LamArie S Belldegrun
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·H IkushimaK Nomura
Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Steven B CannadyJohn H Suh
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·M WrónskiV A Levin
Feb 19, 2004·Urologic Oncology·Georges NoelJean-Jacques Mazeron
Apr 29, 1998·International Journal of Urology : Official Journal of the Japanese Urological Association·K YamanakaS Kamidono
Aug 22, 2002·Neurosurgery·Paul D BrownRobert L Foote
Aug 30, 2005·Neurologia Medico-chirurgica·Takashi SadatomoKaoru Kurisu
May 4, 2000·Journal of Neurosurgery·B R PayneL Steiner
May 7, 2002·Journal of Neurosurgery·Steffen K RosahlMadjid Samii
Oct 31, 2002·Journal of Neurosurgery·Berndt WowraAlfons Hofstetter
Feb 18, 2014·Cancer Chemotherapy and Pharmacology·Xavier García Del MuroDaniel Castellano
Oct 11, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Blanca Paño BrufauCarlos Nicolau Molina
Sep 28, 2013·Neurological Research·Kaisorn L ChaichanaAlfredo Quinones-Hinojosa
Aug 6, 2013·Acta neurochirurgica·Gabriele SchackertMatthias Kirsch
Jul 19, 2011·Hematology/oncology Clinics of North America·Jose A Karam, Christopher G Wood
May 22, 2010·International Journal of Radiation Oncology, Biology, Physics·Dirk RadesSteven E Schild
Dec 17, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·S GaillardS Aldea
Nov 11, 2008·The Urologic Clinics of North America·Paul Russo, Matthew Francis O'Brien
Jun 15, 2007·Seminars in Oncology·Andrew A KannerZvi Ram
May 10, 2005·BJU International·Michael StaehlerMichael Siebels
Sep 24, 2010·Cancer·Martin E GoreCezary Szczylik
Dec 10, 2013·Acta Neurologica Scandinavica·S G RogneT R Meling
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Samuel T ChaoJohn H Suh
Dec 19, 2003·The Urologic Clinics of North America·Nicolette K JanzenArie S Belldegrun
Apr 15, 2003·Neurologic Clinics·Patrick Y Wen, David Schiff
Mar 19, 2014·Neuro-Chirurgie·O BennaniF Proust

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.